首頁 > 市場調查報告書 > 醫療設備

傷口護理

市場調查報告書

商品編碼

1916076

2025-2029年全球創傷護理生物製藥市場

Global Wound Care Biologic Market 2025-2029

出版日期: 2026年01月19日 | 出版商:

TechNavio | 英文 313 Pages | 訂單完成後即時交付

價格

簡介目錄

全球創傷護理生物製藥市場預估於2024年至2029年間成長7.013億美元，預測期內複合年成長率（CAGR）為5.5%。本報告對全球創傷護理生物製藥市場進行了全面分析，包括市場規模和預測、趨勢、成長要素和挑戰，以及對約25家公司的供應商分析。

該報告對當前市場狀況、最新趨勢和促進因素以及整體市場環境進行了最新分析。市場成長的促進因素包括慢性病增加和人口老化、技術進步和產品創新，以及老年人口的成長。

本研究採用客觀的方法，結合一手和二手訊息，包括來自主要行業相關人員的意見。報告包含全面的市場規模數據、區域細分分析、供應商格局以及對主要企業的分析。報告提供歷史數據和預測數據。

市場覆蓋範圍
基準年	2025
年末	2029
預測期	2025-2029
成長勢頭	加速度
同比	5.2%
複合年成長率	5.5%
增量	7.013億美元

研究強調，聯合治療和生物活性敷料的興起將是未來幾年推動全球創傷護理生物製藥市場成長的關鍵因素之一。此外，護理模式向門診和居家環境的轉變，以及透過併購的市場整合加劇，預計也將顯著提升市場需求。

區域細分
區域比較
北美洲
- 美國
- 加拿大
- 墨西哥
歐洲
- 德國
- 英國
- 法國
- 俄羅斯
- 義大利
- 荷蘭
- 西班牙
亞洲
- 中國
- 日本
- 印度
- 韓國
- 新加坡
- 印尼
- 泰國
世界其他地區
- 巴西
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 澳洲
- 南非
- 土耳其
各區域的市場機遇

第13章：促進因素、挑戰與機遇

市場促進因素
市場挑戰
促進因素和挑戰的影響
市場機遇

第14章競爭格局

概述
競爭格局
令人困惑的局面
產業風險

第15章競爭分析

公司簡介
企業排名指數
公司市場定位
Amnio Technology LLC
Aroa Biosurgery Ltd.
Avita Medical Inc.
B.Braun SE
Coloplast AS
Integra LifeSciences Corp.
Kerecis Ltd.
Marine Polymer Technologies Inc.
Medline Industries LP
MiMedx Group Inc.
Molnlycke Health Care AB
Organogenesis Holdings Inc.
Smith and Nephew plc
Stryker Corp.
Vericel Corp.

第16章附錄

簡介目錄

Product Code: IRTNTR81124

The global wound care biologic market is forecasted to grow by USD 701.3 mn during 2024-2029, accelerating at a CAGR of 5.5% during the forecast period. The report on the global wound care biologic market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of chronic diseases and aging population, technological advancements and product innovation, growing number of geriatric populations.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Market Scope
Base Year	2025
End Year	2029
Series Year	2025-2029
Growth Momentum	Accelerate
YOY 2025	5.2%
CAGR	5.5%
Incremental Value	$701.3 mn

Technavio's global wound care biologic market is segmented as below:

By Product

Skin substitutes
Cell based products
Collagen based products
Topical agents
Others

By Application

Ulcers
Surgical and traumatic wounds
Burns
Others

By End-User

Hospitals and clinics
ASCs
Burn centers and wound clinics
Others

Geography

North America
- US
- Canada
- Mexico
Europe
- Germany
- UK
- France
- Russia
- Italy
- The Netherlands
- Spain
Asia
Rest of World (ROW)
Rest of World (ROW)

This study identifies the rise of combination therapies and bioactive dressings as one of the prime reasons driving the global wound care biologic market growth during the next few years. Also, shift in point of care to outpatient and home settings and increased consolidation through mergers and acquisitions will lead to sizable demand in the market.

The report on the global wound care biologic market covers the following areas:

Global wound care biologic market sizing
Global wound care biologic market forecast
Global wound care biologic market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global wound care biologic market vendors that include Amnio Technology LLC, Aroa Biosurgery Ltd., Avita Medical Inc., B.Braun SE, Celularity Inc., Coloplast AS, ConvaTec Group Plc, Derma Sciences Inc., Integra LifeSciences Corp., Kerecis Ltd., Marine Polymer Technologies Inc., Medline Industries LP, MiMedx Group Inc., Molnlycke Health Care AB, Organogenesis Holdings Inc., Skye Biologics Holdings LLC, Smith and Nephew plc, Stryker Corp., Vericel Corp.. Also, the global wound care biologic market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

1 Executive Summary

1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Product
- Executive Summary - Chart on Market Segmentation by Application
- Executive Summary - Chart on Market Segmentation by End-user
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
2.3 Factors of disruption
2.4 Impact of drivers and challenges

3 Market Landscape

3.1 Market ecosystem
3.2 Market characteristics
3.3 Value chain analysis

4 Market Sizing

4.1 Market definition
4.2 Market segment analysis
- Market segments
4.3 Market size 2024
4.4 Market outlook: Forecast for 2024-2029

5 Historic Market Size

5.1 Global Wound Care Biologic Market 2019 - 2023
- Historic Market Size - Data Table on Global Wound Care Biologic Market 2019 - 2023 ($ million)
5.2 Product segment analysis 2019 - 2023
- Historic Market Size - Product Segment 2019 - 2023 ($ million)
5.3 Application segment analysis 2019 - 2023
- Historic Market Size - Application Segment 2019 - 2023 ($ million)
5.4 End-user segment analysis 2019 - 2023
- Historic Market Size - End-user Segment 2019 - 2023 ($ million)
5.5 Geography segment analysis 2019 - 2023
- Historic Market Size - Geography Segment 2019 - 2023 ($ million)
5.6 Country segment analysis 2019 - 2023
- Historic Market Size - Country Segment 2019 - 2023 ($ million)

6 Qualitative Analysis

6.1 Impact of AI in the global wound care biologic market

7 Five Forces Analysis

7.1 Five forces summary
- Five forces analysis - Comparison between 2024 and 2029
7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2024 and 2029
7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2024 and 2029
7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2024 and 2029
7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2024 and 2029
7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2024 and 2029
7.7 Market condition

8 Market Segmentation by Product

8.1 Market segments
8.2 Comparison by Product
8.3 Skin substitutes - Market size and forecast 2024-2029
8.4 Cell based products - Market size and forecast 2024-2029
8.5 Collagen based products - Market size and forecast 2024-2029
8.6 Topical agents - Market size and forecast 2024-2029
8.7 Others - Market size and forecast 2024-2029
8.8 Market opportunity by Product
- Market opportunity by Product ($ million)

9 Market Segmentation by Application

9.1 Market segments
9.2 Comparison by Application
9.3 Ulcers - Market size and forecast 2024-2029
9.4 Surgical and traumatic wounds - Market size and forecast 2024-2029
9.5 Burns - Market size and forecast 2024-2029
9.6 Others - Market size and forecast 2024-2029
9.7 Market opportunity by Application
- Market opportunity by Application ($ million)

10 Market Segmentation by End-user

10.1 Market segments
10.2 Comparison by End-user
10.3 Hospitals and clinics - Market size and forecast 2024-2029
10.4 ASCs - Market size and forecast 2024-2029
10.5 Burn centers and wound clinics - Market size and forecast 2024-2029
10.6 Others - Market size and forecast 2024-2029
10.7 Market opportunity by End-user
- Market opportunity by End-user ($ million)

11 Customer Landscape

11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

12.1 Geographic segmentation
12.2 Geographic comparison
12.3 North America - Market size and forecast 2024-2029
- 12.3.1 US - Market size and forecast 2024-2029
- 12.3.2 Canada - Market size and forecast 2024-2029
- 12.3.3 Mexico - Market size and forecast 2024-2029
12.4 Europe - Market size and forecast 2024-2029
- 12.4.1 Germany - Market size and forecast 2024-2029
- 12.4.2 UK - Market size and forecast 2024-2029
- 12.4.3 France - Market size and forecast 2024-2029
- 12.4.4 Russia - Market size and forecast 2024-2029
- 12.4.5 Italy - Market size and forecast 2024-2029
- 12.4.6 The Netherlands - Market size and forecast 2024-2029
- 12.4.7 Spain - Market size and forecast 2024-2029
12.5 Asia - Market size and forecast 2024-2029
- 12.5.1 China - Market size and forecast 2024-2029
- 12.5.2 Japan - Market size and forecast 2024-2029
- 12.5.3 India - Market size and forecast 2024-2029
- 12.5.4 South Korea - Market size and forecast 2024-2029
- 12.5.5 Singapore - Market size and forecast 2024-2029
- 12.5.6 Indonesia - Market size and forecast 2024-2029
- 12.5.7 Thailand - Market size and forecast 2024-2029
12.6 Rest of World (ROW) - Market size and forecast 2024-2029
- 12.6.1 Brazil - Market size and forecast 2024-2029
- 12.6.2 Saudi Arabia - Market size and forecast 2024-2029
- 12.6.3 UAE - Market size and forecast 2024-2029
- 12.6.4 Australia - Market size and forecast 2024-2029
- 12.6.5 South Africa - Market size and forecast 2024-2029
- 12.6.6 Turkey - Market size and forecast 2024-2029
12.7 Market opportunity by geography
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)

13 Drivers, Challenges, and Opportunity

13.1 Market drivers
- Increasing prevalence of chronic diseases and aging population
- Technological advancements and product innovation
- Growing number of geriatric populations
13.2 Market challenges
- High cost and inconsistent reimbursement frameworks
- Stringent and evolving regulatory hurdles in market
- Competition from traditional wound care and deficient clinician awareness
13.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029
13.4 Market opportunities
- Rise of combination therapies and bioactive dressings
- Shift in point of care to outpatient and home settings
- Increased consolidation through mergers and acquisitions

14 Competitive Landscape

14.1 Overview
14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
14.3 Landscape disruption
- Overview on factors of disruption
14.4 Industry risks
- Impact of key risks on business

15 Competitive Analysis

15.1 Companies profiled
- Companies covered
15.2 Company ranking index
- Company ranking index
15.3 Market positioning of companies
- Matrix on companies position and classification
15.4 Amnio Technology LLC
- Amnio Technology LLC - Overview
- Amnio Technology LLC - Product / Service
- Amnio Technology LLC - Key offerings
- SWOT
15.5 Aroa Biosurgery Ltd.
- Aroa Biosurgery Ltd. - Overview
- Aroa Biosurgery Ltd. - Product / Service
- Aroa Biosurgery Ltd. - Key offerings
- SWOT
15.6 Avita Medical Inc.
- Avita Medical Inc. - Overview
- Avita Medical Inc. - Product / Service
- Avita Medical Inc. - Key offerings
- SWOT
15.7 B.Braun SE
- B.Braun SE - Overview
- B.Braun SE - Product / Service
- B.Braun SE - Key news
- B.Braun SE - Key offerings
- SWOT
15.8 Coloplast AS
- Coloplast AS - Overview
- Coloplast AS - Business segments
- Coloplast AS - Key news
- Coloplast AS - Key offerings
- Coloplast AS - Segment focus
- SWOT
15.9 Integra LifeSciences Corp.
- Integra LifeSciences Corp. - Overview
- Integra LifeSciences Corp. - Business segments
- Integra LifeSciences Corp. - Key news
- Integra LifeSciences Corp. - Key offerings
- Integra LifeSciences Corp. - Segment focus
- SWOT
15.10 Kerecis Ltd.
- Kerecis Ltd. - Overview
- Kerecis Ltd. - Product / Service
- Kerecis Ltd. - Key offerings
- SWOT
15.11 Marine Polymer Technologies Inc.
- Marine Polymer Technologies Inc. - Overview
- Marine Polymer Technologies Inc. - Product / Service
- Marine Polymer Technologies Inc. - Key offerings
- SWOT
15.12 Medline Industries LP
- Medline Industries LP - Overview
- Medline Industries LP - Product / Service
- Medline Industries LP - Key offerings
- SWOT
15.13 MiMedx Group Inc.
- MiMedx Group Inc. - Overview
- MiMedx Group Inc. - Business segments
- MiMedx Group Inc. - Key offerings
- MiMedx Group Inc. - Segment focus
- SWOT
15.14 Molnlycke Health Care AB
- Molnlycke Health Care AB - Overview
- Molnlycke Health Care AB - Product / Service
- Molnlycke Health Care AB - Key offerings
- SWOT
15.15 Organogenesis Holdings Inc.
- Organogenesis Holdings Inc. - Overview
- Organogenesis Holdings Inc. - Product / Service
- Organogenesis Holdings Inc. - Key offerings
- SWOT
15.16 Smith and Nephew plc
- Smith and Nephew plc - Overview
- Smith and Nephew plc - Business segments
- Smith and Nephew plc - Key news
- Smith and Nephew plc - Key offerings
- Smith and Nephew plc - Segment focus
- SWOT
15.17 Stryker Corp.
- Stryker Corp. - Overview
- Stryker Corp. - Business segments
- Stryker Corp. - Key news
- Stryker Corp. - Key offerings
- Stryker Corp. - Segment focus
- SWOT
15.18 Vericel Corp.
- Vericel Corp. - Overview
- Vericel Corp. - Product / Service
- Vericel Corp. - Key offerings
- SWOT

16 Appendix

16.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
16.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
16.3 Currency conversion rates for US$
- Currency conversion rates for US$
16.4 Research methodology
- Research methodology
16.5 Data procurement
- Information sources
16.6 Data validation
- Data validation
16.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
16.8 Data synthesis
- Data synthesis
16.9 360 degree market analysis
- 360 degree market analysis
16.10 List of abbreviations
- List of abbreviations